These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 33152448
1. Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children. Gargiulo A, Massella L, Ruggiero B, Ravà L, Ciofi Degli Atti M, Materassi M, Lugani F, Benetti E, Morello W, Molino D, Mattozzi F, Pennesi M, Maringhini S, Pasini A, Gianoglio B, Pecoraro C, Montini G, Murer L, Ghiggeri GM, Romagnani P, Vivarelli M, Emma F. Kidney Int; 2021 Feb; 99(2):475-483. PubMed ID: 33152448 [Abstract] [Full Text] [Related]
2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ. Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083 [Abstract] [Full Text] [Related]
13. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial. Kainth D, Hari P, Sinha A, Pandey S, Bagga A. Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976 [Abstract] [Full Text] [Related]
16. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A. Kidney Int; 2019 Jan 08; 95(1):210-218. PubMed ID: 30497684 [Abstract] [Full Text] [Related]
20. Non-corticosteroid treatment for nephrotic syndrome in children. Durkan A, Hodson E, Willis N, Craig J. Cochrane Database Syst Rev; 2001 Jan 08; (4):CD002290. PubMed ID: 11687155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]